SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053540
Filing Date
2020-11-12
Accepted
2020-11-12 16:03:00
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-10q_20200930.htm 10-Q 3186474
2 EX-31.1 pcvx-ex311_7.htm EX-31.1 17229
3 EX-31.2 pcvx-ex312_6.htm EX-31.2 18202
4 EX-32.1 pcvx-ex321_9.htm EX-32.1 9388
5 EX-32.2 pcvx-ex322_8.htm EX-32.2 9399
  Complete submission text file 0001564590-20-053540.txt   8731293

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pcvx-20200930.xml EX-101.INS 1519685
7 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20200930.xsd EX-101.SCH 59207
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pcvx-20200930_cal.xml EX-101.CAL 36072
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pcvx-20200930_def.xml EX-101.DEF 273322
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20200930_lab.xml EX-101.LAB 443784
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20200930_pre.xml EX-101.PRE 399638
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 201306534
SIC: 2836 Biological Products, (No Diagnostic Substances)